51³Ô¹ÏÍø

RUSHES: Coronavirus: Downing Street press briefing 28th April 2021

Coronavirus: Downing Street press briefing 28th April 2021; Clip 6 of 13 ENGLAND: London: Downing Street: Media briefing room: INT Matt Hancock MP (Health Secretary) press conference SOT - Thanks very much. The next question is from Melanie in Derbyshire by text. And Melanie asks: during the pandemic, the UK has emerged as a powerhouse of biomedical research, innovation, and development. What plans does the government have to continue this beyond COVID and make the UK a global leader in this area? Melanie, this is an incredibly important question. And in fact, after being vaccinated tomorrow morning, I’m then going to give a speech on precisely this topic. So you’ve asked at a very good moment. The truth is, in my view, and I’ll ask the scientific view in a moment, the truth is that in this pandemic, the UK life sciences and biomedical research have given a huge amount to the world. Probably our greatest contribution to saving lives and tackling this pandemic around the world is the Oxford AstraZeneca vaccine, and in particular, the decision to ensure that it’s provided at cost without any charge for profit or intellectual property. It’s been a huge and heroic effort. And I’m very grateful to the team at Oxford and the team at AstraZeneca who’ve done an absolutely amazing job of making this happen. And then the capabilities, for instance, in clinical trials, because it’s in the UK clinical trials that we’ve discovered the most drugs that work to save people’s lives. First, of course, the dexamethasone, which they estimate has saved up to a million lives around the world already. To make sure that this is very successful going forward, we’re going to ensure that we attract onshore here in the UK, not just the research, the innovation, the development that you mentioned, but also the manufacturing of these products. We want to make it an impossible choice for a pharmaceutical company not to invest in the UK. And one of our commitments is that we will not eve...
Coronavirus: Downing Street press briefing 28th April 2021; Clip 6 of 13 ENGLAND: London: Downing Street: Media briefing room: INT Matt Hancock MP (Health Secretary) press conference SOT - Thanks very much. The next question is from Melanie in Derbyshire by text. And Melanie asks: during the pandemic, the UK has emerged as a powerhouse of biomedical research, innovation, and development. What plans does the government have to continue this beyond COVID and make the UK a global leader in this area? Melanie, this is an incredibly important question. And in fact, after being vaccinated tomorrow morning, I’m then going to give a speech on precisely this topic. So you’ve asked at a very good moment. The truth is, in my view, and I’ll ask the scientific view in a moment, the truth is that in this pandemic, the UK life sciences and biomedical research have given a huge amount to the world. Probably our greatest contribution to saving lives and tackling this pandemic around the world is the Oxford AstraZeneca vaccine, and in particular, the decision to ensure that it’s provided at cost without any charge for profit or intellectual property. It’s been a huge and heroic effort. And I’m very grateful to the team at Oxford and the team at AstraZeneca who’ve done an absolutely amazing job of making this happen. And then the capabilities, for instance, in clinical trials, because it’s in the UK clinical trials that we’ve discovered the most drugs that work to save people’s lives. First, of course, the dexamethasone, which they estimate has saved up to a million lives around the world already. To make sure that this is very successful going forward, we’re going to ensure that we attract onshore here in the UK, not just the research, the innovation, the development that you mentioned, but also the manufacturing of these products. We want to make it an impossible choice for a pharmaceutical company not to invest in the UK. And one of our commitments is that we will not eve...
PURCHASE A LICENSE

Get personalized pricing by telling us when, where, and how you want to use this asset.

DETAILS

Restrictions:
No use by national or regional TV or radio news in UK and Ireland until 4 days after date of creation. Prior approval required if clip features ITN newsreader or reporter in sound or vision, please contact your local Getty Images representative.
Credit:
Editorial #:
1315216486
Collection:
ITN
Date created:
April 28, 2021
Upload date:
License type:
Rights-ready
Release info:
Not released.ÌýMore information
Clip length:
00:05:09:03
Location:
United Kingdom
Mastered to:
QuickTime 8-bit H.264 HD 1920x1080 25p
Originally shot on:
1080 25i
Source:
ITN
Object name:
r280421005_35181